Patents by Inventor Veit Schmelmer

Veit Schmelmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSING REGIMENS FOR THE MOBILIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS
    Publication number: 20220401481
    Abstract: The invention provides compositions and methods useful for mobilizing populations of hematopoietic stem and progenitor cells within a donor, as well as for determining whether samples of mobilized cells are suitable for release for ex vivo expansion and/or therapeutic use. In accordance with the compositions and methods described herein, mobilized hematopoietic stem and progenitor cells can be withdrawn from a donor and administered to a patient for the treatment of various stem cell disorders, including hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases, among others.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 22, 2022
    Inventors: Anthony Boitano, Michael P. Cooke, John C. Davis, Patrick C. Falahee, Kevin A. Goncalves, Sharon Hyzy, Dwight Morrow, Jason Neale, Glen Raffel, William Savage, Veit Schmelmer
  • Process for preparing an oral suspension of a pharmaceutical substance
    Patent number: 6682747
    Abstract: The present invention relates to orally administered suspensions of pharmaceutical active substances of the NSAID type, particularly the antirheumatic agent Meloxicam, which are stabilized by the addition of small amounts of highly dispersed silicon dioxide using high shear forces and adding small amounts of hydrophilic polymers to form a three-dimensional siloid structure, and a process for the preparation thereof.
    Type: Grant
    Filed: November 7, 2000
    Date of Patent: January 27, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Dietrich Türck, Veit Schmelmer
  • Oral suspension of pharmaceutical substance
    Patent number: 6184220
    Abstract: The present invention relates to orally administered suspensions of pharmaceutical active substances of the NSAID type, particularly the antirheumatic agent Meloxicam, which are stabilized by the addition of small amounts of highly dispersed silicon dioxide using high shear forces and adding small amounts of hydrophilic polymers to form a three-dimensional siloid structure, and a process for the preparation thereof.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: February 6, 2001
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Dietrich Türck, Veit Schmelmer